the development of alcoholism by acetaldehydemia and alcohol Alcohol dehydrogenase-2 (ADH2) and aldehyde dehydroflushing responses (8) , the preventive effect of heterozygous genase-2 (ALDH2) gene polymorphisms play roles in eth-ALDH2*1/2*2 is incomplete. Approximately 10% of Japanese anol metabolism, drinking behavior and esophageal alcoholics have ALDH2*1/2*2 (4). carcinogenesis in Japanese; however, the combined influStudies of various Japanese drinking populations have shown ence of ADH2 and ALDH2 genotypes on other aerodigestive that the inactive form of ALDH2 encoded by the gene tract cancers have not been investigated. ADH2/ALDH2 ALDH2*1/2*2 is a risk factor for oropharyngolaryngeal (9,10) genotyping was performed on lymphocyte DNA samples and esophageal cancers (9, (11) (12) (13) . Synchronous (14) and from Japanese alcoholic men (526 cancer-free; 159 with metachronous (15) multiple esophageal cancers have been solitary or multiple aerodigestive tract cancers, including found more frequently in Japanese alcoholics with the inactive 33 oropharyngolaryngeal, 112 esophageal, 38 stomach and ALDH2 than in those without it. In Japanese head and neck 22 multiple primary cancers in two or three organs). After cancer patients, inactive ALDH2 was a risk indicator for adjustment for age, drinking and smoking habits, and the presence of multiple esophageal iodine-unstained lesions, ADH2/ALDH2 genotypes, the presence of either ADH2*1/ which consist mainly of squamous epithelial dysplasia (16). 2*1 or ALDH2*1/2*2 significantly increased the risk for
Because acetaldehyde is an established animal carcinogen oropharyngolaryngeal cancer [odds ratios (ORs), 6 .68 with (17, 18) , all this evidence points to a role for acetaldehyde in ADH2*1/2*1 and 18.52 with ALDH2*1/2*2] and esophageal the development of human cancers. cancer (ORs, 2.64 and 13.50, respectively). For patients Our screening of Japanese male alcoholics, using upper with both ADH2*1/2*1 and ALDH2*1/2*2, the risks for gastrointestinal endoscopy combined with oropharyngolarynoropharyngolaryngeal and esophageal cancers were geal inspection and esophageal iodine staining, detected aeroenhanced in a multiplicative fashion (OR ⍧ 121.77 and digestive tract cancer at extremely high rates (19,20).
40.40, respectively). A positive association with ALDH2*1/
Synchronous and metachronous multiple esophageal cancers 2*2 alone was observed for stomach cancer patients who have been also frequently found in this population (14, 15) . also had oropharyngolaryngeal and/or esophageal cancer
The high rate of detected esophageal cancer is primarily due (OR ⍧ 110.58), but it was not observed for those with to the improved method of detection (esophageal iodine stomach cancer alone. Furthermore, in the presence of staining), but enhanced susceptibility by persons with inactive ALDH2*1/2*2, the risks for multiple intra-esophageal can-ALDH2 also explains the extremely high rate in Japanese cers (OR ⍧ 3.43) and for esophageal cancer with oroalcoholics. pharyngolaryngeal and/or stomach cancer (OR ⍧ 3.95)
A genetic polymorphism of alcohol dehydrogenase-2 were higher than the risks for solitary intra-esophageal (ADH2) also has striking racial differences. The mutant cancer and for esophageal cancer alone, but these tenden-ADH2*2 allele, which is highly prevalent among Asians [e.g. cies were not observed for ADH2*1/2*1 genotype. Alco-93% of Japanese (4)], encodes a superactive subunit of ADH2. holics' population attributable risks due to ADH2/ALDH2
The homodimer of ADH2 encoded by ADH2*1/2*1 has only polymorphisms were estimated to be 82.0% for oropharyn-1/100 and 1/200 of the ethanol oxidation capacity of the golaryngeal cancer and 63.9% for esophageal cancer.
isozymes encoded by ADH2*1/2*2 and ADH2*2/2*2, respectively (21). The ADH2*2 allele has been found in only about 10% of Caucasians (5).
Introduction
Inactive ALDH2 is responsible for most of the intense Epidemiologic studies have consistently demonstrated that flushing responses in Asians, but the ADH2*2 allele also drinking alcoholic beverages is causally related to the developcontributes to alcohol flushing (22-24) and prevents people ment of cancer in the oral cavity, pharynx, larynx and esophagus from developing alcoholism (4, 25) . Recently, the ADH2*1/ 2*1 genotype has been reported to be more strongly associated with the development of esophageal cancer than the ADH2*1/ general populations (12) of Japan. The aim of this study was respectively; pd i is the observed proportion of cases with the ith combination For reference, we used data from 526 Japanese male alcoholics aged 40 of ADH2 and ALDH2 genotypes; RR i is the adjusted relative risk (approxiyears or older without cancer who were consecutively admitted to the Institute mated by OR) compared with the reference category (i ϭ 0) that yields the between January 1996 and May 1998. None of these patients had a history lowest risk. All analyses were done with the SAS statistical package (version of cancer, and all were diagnosed as cancer-free by systematic examination 6.12; SAS Institute, Cary, NC). using chest X-rays plus upper gastrointestinal endoscopy combined with oropharyngolaryngeal inspection and esophageal iodine staining, immunoch-
Results
emical fecal occult blood tests with subsequent double-contrast barium enema and/or colonoscopy and abdominal ultrasound.
The patients with esophageal or stomach cancers were significThe proposed study was reviewed and approved by the ethics committee antly older than the cancer-free patients (Table I) . As for daily of the Institute, and informed consent was obtained from each participating alcohol consumption, there were no differences between the patient.
cancer patients and controls. We observed more smoking ively) were higher than in the cancer-free patients (27.6 and Beer was considered to be 5% ethanol (v/v); wine, 12%; sake, 16%; shochu, 25%; and whiskey, 40%.
9.5%, respectively; Table II) . Because, as previously reported (24) , there were no different effects on cancer risk between ADH2 and ALDH2 genotyping the ADH2*1/2*2 and ADH2*2/2*2 genotypes, we combined ADH2, ALDH2 genes and cancer and/or esophageal cancer, we observed a strong association cancer and for esophageal cancer alone. We did not observe these tendencies for the ADH2*1/2*1 genotype (Table V) . with ALDH2*1/2*2 (OR ϭ 110.58). The OR of 0.98 suggested that the ADH2*1/2*1 genotype has no effect on the development of stomach cancer (Table IV) . Discussion The risks for multiple intra-esophageal cancers (OR ϭ 3.43) and for esophageal cancer with oropharyngolaryngeal and/or Recently, we demonstrated that the ADH2*1/2*1 and ALDH2*1/2*2 genotypes potentiate the carcinogenic effects stomach cancer (OR ϭ 3.95) were higher in the presence of ALDH2*1/2*2 than the risks for solitary intra-esophageal of alcohol on the esophagus in Japanese alcoholics (24) . The present study clearly revealed similar effects for the ADH2*1/ Japanese from alcoholism: 69% of our Japanese alcoholics had this allele, compared with 93% of healthy controls (4). 2*1 and ALDH2*1/2*2 genotypes on susceptibility to cancers of the oral cavity/oropharynx and epilarynx/hypopharynx in This evidence suggests that cancer risks for ADH2 and ALDH2 genotypes should be adjusted by alcohol consumption. Another Japanese alcoholics and showed that multiple field cancerization of the oropharyngolaryngeal sites, esophagus and stomach study, carried out in the surgical department of a general hospital, showed high frequencies of ADH2*1/2*1 and in the population is strongly influenced by ALDH2*1/2*2, but not by ADH2*1/2*1. The adjusted estimate of population ALDH2*1/2*2 genotypes (22 and 75%, respectively) among the esophageal cancer patients, 93% of whom were drinkers attributable risks showed that a surprisingly high proportion of cases with oropharyngolaryngeal and esophageal cancer or smokers (12) . The findings are consistent with those of the present study. However, in that study (12) the investigators could be linked to the ADH2 and ALDH2 gene polymorphisms. The extraordinarily great influence of gene polymorphisms calculated the patients' risk in comparison with that of only healthy control subjects without adjustment for alcohol conmay be related to the study population's homogeneity with regard to their extremely high alcohol consumption.
sumption. Moreover, they overestimated the risk associated with ADH2*1/2*1 and underestimated that for ALDH2*1/2*2. This gene-based cancer susceptibility adds a new dimension to the alcohol-cancer enigma. In individuals with inactive
The present study conducted in an alcoholic population showed cancer risks at only the highest level of alcohol ALDH2 encoded by ALDH2*1/2*2, the blood acetaldehyde level after drinking is~6-fold the concentration in those exposure. At that level, both ADH2*1/2*1 and ALDH2*1/2*2 increased the risks considerably, but the role of ALDH2*1/2*2 with active ALDH2 (7). There is sufficient evidence of acetaldehyde's carcinogenicity in experimental animals predominated; the odds ratios for ALDH2*1/2*2 were 3-to 5-fold those for ADH2*1/2*1 with respect to the oropharyngola-(17,18). In addition, its ability to form DNA adducts in humans may represent a critical initiating event in the process of ryngeal and esophageal cancers. Our previous estimate of ALDH2*1/2*2-associated risk for carcinogenesis. The levels of acetaldehyde adducts in leukocyte DNA from alcoholics are much higher than those in healthy non-alcoholic everyday drinkers with esophageal cancer (11), whose average daily alcohol consumption was approximately controls (30) , and chromosome alterations have been observed more frequently in lymphocytes from drinkers with inactive half that of the alcoholics, is close to the odds ratio for ALDH2*1/2*2 found in this study. From the public health ALDH2 (31). Together, this evidence of ALDH2-associated susceptibility suggests that acetaldehyde plays a pivotal role point of view, gene-based susceptibility to the carcinogenic action of alcohol may have more important implications at in carcinogenesis in alcoholics.
Although investigators have failed to establish any correlalow levels of exposure. Among populations of European origin, a beneficial effect of light drinking has been demonstrated tion between ADH2 genotype and peak levels of blood acetaldehyde after drinking (7), the high-risk ADH2 encoded by (32) . Regardless of whether this is the case for Asians, carcinogenic interactions between the genotypes of alcohol-ADH2*1/2*1 has only a small fraction of the activity of the isozymes encoded by the ADH2*2 allele (21) and individuals metabolizing enzymes and light alcohol consumption should be investigated. with ADH2*1/2*1 might be exposed to lower doses of acetaldehyde following heavy alcohol drinking. That would argue
There is a paradox in Japanese esophageal cancer statistics: per capita alcohol consumption by Japanese males is lower against the important role of acetaldehyde in carcinogenesis of alcoholics. ADH2*1/2*1 might, under certain conditions, than that by European and American males (due to the high prevalence of ADH2*2 and ALDH2*2 alleles in Japanese); increase the risks for oropharyngolaryngeal and esophageal cancer via other mechanisms of the interaction between genes however, the death rates for esophageal cancer rank higher for Japanese males than for men from Western nations (33) . and drinking behavior.
The ADH2*1/2*1 and ALDH2*1/2*2 genotypes, each of Although some differences in other risk factors such as smoking and diet influence esophageal cancer mortality [e.g. higher which encodes the inactive form of its isozyme, have opposing effects on drinking behavior (4, 25) . ALDH2*1/2*2 generally prevalence of smoking among Japanese males than among Western males (34)], this paradox might be explained, in part, serves as a strong protective factor against alcoholism, as exemplified by our earlier study, in which 12% of Japanese by the carcinogenic role of ALDH2*1/2*2 in Japanese, which predominates over the influence of ADH2*1/2*1 prevailing in alcoholics had inactive ALDH2, compared with 42% of healthy controls (4). In addition, the ADH2*2 allele also protects many Europeans and Americans.
We cannot adequately explain why inactive ALDH2 and cases classified in the highest category of alcohol consumption (ജ121 g/day). In the present study, the cancer risks from severe acetaldehydemia selectively influence the development of cancers on the oropharyngolaryngeal sites and esophagus. ADH2*1/2*1 and ALDH2*1/2*2 were similarly enhanced for the oral cavity/oropharynx and epilarynx/hypopharynx; One possible explanation is related to topical acetaldehyde exposure and accumulation in these organs. In addition to however, we found only two patients with endolaryngeal cancer. The disproportionate rarity of endolaryngeal cancer systemic acetaldehyde exposure, these organs are exposed to acetaldehyde derived from salivary and mucosal production.
compared with epilaryngeal/hypopharyngeal cancer in Japanese alcoholics might, at least in part, be explained by the An alcohol-challenge test showed that the salivary acetaldehyde levels in Asians with ALDH2*1/2*2 were 9-fold higher than enhanced carcinogenic effect of alcohol on oropharyngolaryngeal subsites excluding the endolarynx, where the effect of their blood acetaldehyde levels and 2-3-fold higher than the salivary acetaldehyde levels in those with ALDH2*1/2*1 (35).
tobacco seems to be more important. Of two Japanese casecontrol studies recently investigating the association between The gingiva, tongue and esophagus strongly express high K m ADH7, which would be very active in producing acetaldehyde the ALDH2 genotype and the risk for oral cancer, one showed increased risk in the presence of ALDH2*1/2*2 in moderate upon exposure to a locally higher ethanol dose than most other organs, including the liver. Moreover, these organs lack ALDH2 drinkers (10), although the magnitude of increased risk (OR ϭ 2.9) was considerably lower than the risk in alcoholics. The activity (36, 37) , suggesting that after exposure to acetaldehyde derived from systemic, salivary or mucosal production, these other study showed neither alcohol consumption nor ALDH2 genotype to be associated with cancer risk (41) . In some nonorgans' inefficient degradation of acetaldehyde enhances the chances for local acetaldehyde-associated carcinogenesis.
alcoholic populations, alcohol actions and ALDH2 effects on oral carcinogenesis may be less important than other risk factors Our results show that ADH2*1/2*1 combines with ALDH2*1/2*2 to enhance the risks for oropharyngolaryngeal such as smoking, poor dentition and inadequate oral hygiene.
We have previously reported frequently finding multiple and esophageal cancers in a multiplicative fashion. Recently, using simple questions to learn about current or former facial intra-esophageal cancers and multiple esophageal cancers with oropharyngolaryngeal and/or stomach cancer in Japanese alcoflushing after drinking a glass of beer, we showed that, among alcoholics with ALDH2*1/2*2 who had esophageal cancer, holics, especially those with ALDH2*1/2*2 (14, 15, 20) . The present findings show that the role of ALDH2*1/2*1 predomin-52% of those who also had ADH2*1/2*1 had never experienced alcohol flushing. Of those with both ALDH2*1/2*2 and ates for multiple field cancerization, but that the ADH2 genotype is not associated with this multiplicity. Our observa-ADH2*2 alleles, 92% reported current or former flushing (24) . Accordingly, individuals with the combination of ADH2*1/ tions indicated that these multiple cancers were strongly associated with severe acetaldehyde exposure, and suggested 2*1 and ALDH2*1/2*2 should be at high risk for acetaldehyderelated cancers because, as a result of their lack of protective that the role of ADH2*1/2*1 in carcinogenesis might differ from the acetaldehyde scenario. The slightly higher odds ratios flushing, they are more likely to drink to experience accelerated development of alcoholism, and thus to be exposed to higher of oropharyngolaryngeal cancer for ALDH2*1/2*2 (ORs ϭ 18.52-28.92) compared with esophageal cancer (OR ϭ 13.50) levels of acetaldehyde earlier in life. However, because ADH2*1/2*1 increased the risk of oropharyngolaryngeal and could be explained by different frequencies of multiple cancers in these organs between oropharyngolaryngeal cancer patients esophageal cancers, even among the never-flushing alcoholics who have ALDH2*1/2*1, the ADH2 effects cannot be fully (45.5%) and esophageal cancer patients (19.6%). Stomach cancer is one of the leading cancers in Japan, explained by the influence of alcohol flushing. Some unknown differences in the alcohol metabolism or drinking behaviors where its prevalence is near the highest in the world. There is little epidemiologic evidence that alcoholic beverages play a of alcoholics with and without ADH2*1/2*1 might influence the risk for cancer. Our recent examination of the temporal causal role in stomach cancer (1), but our endoscopic screening has yielded a higher rate of detection of stomach cancer in profile of disease development among alcoholics showed that those with ADH2*1/2*1 experienced each event in the history Japanese alcoholics than in the Japanese general population (20). Molecular epidemiology in the present study showed that of alcoholism (e.g. binge drinking and withdrawal syndrome) earlier in life than those without this genotype (38,39), sugin fact stomach cancer has a relatively weak but significant association with the ALDH2*1/2*2 genotype, but not with gesting that ADH2*1/2*1-mediated acceleration in the occurrence of alcohol-related events contributes to the enhancement the ADH2*1/2*1 genotype. This positive association with ALDH2*1/2*2 was stronger for stomach cancer patients who of cancer risk. During binge drinking, episodic alcohol consumption is generally very high, compared with average daily also had oropharyngolaryngeal and/or esophageal cancer, but it was not observed for those with stomach cancer alone. consumption; however, in the present study, we adjusted cancer risks for the subjects' drinking habits, using only the reported These findings support the hypothesis that the pathogenesis of stomach cancer concurrent with oropharyngolaryngeal and/or daily alcohol consumption during the year preceding cancer diagnosis or admission. Thus we cannot rule out the possibility esophageal cancer is associated with acetaldehyde exposure and distinct from other stomach cancer. The lack of association that we underestimated the confounding effects of drinking behaviors relative to ADH2*1/2*1 genotype.
between stomach cancer and the ADH2 genotype further suggests that, unlike that of ADH2*1/2*1-associated cancers, Epidemiologic studies have shown that the risks for cancer from drinking alcohol differ across the subsites of the orothe high prevalence of stomach cancer might not be associated with alcohol drinking per se but rather with other aspects of pharyngolarynx. An IARC international case-control study of southern European populations showed alcohol's similar disrisk (e.g. diet, nutrition, smoking) in the alcoholics' lifestyle. Regardless of the underlying mechanisms that link ADH2 tinct influence on the risks for epilaryngeal and hypopharyngeal cancers and its weak influence on endolaryngeal cancer risk and ALDH2 genotypes and alcohol-related aerodigestive tract cancers, the identification of flushing responses, which indicate (40); approximately equal numbers were found to have epilaryngeal/hypopharyngeal and endolaryngeal cancer among the inactive ALDH2 and associated risks could serve as a powerful 
